Dishman Carbogen Amcis Limited provides contract research and manufacturing services for the pharmaceutical and healthcare industries worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It offers cholesterol and vitamin D analogs; generic active pharmaceutical ingredients for diagnostics, ophthalmic treatments, laxatives, organophosphate antidotes; ammonium, phosphonium; quats, phosphoranes, and wittig reagents; cholesterol and lanolin-related products; sterile injectables; and softgel formulations, as well as hand and body wash, sanitisers, and antiseptics. The company was founded in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP.
| Current Price | ₹199.10 |
|---|---|
| Market Cap | ₹3,122 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Life Sciences Tools and Services |
| Sub-Industry | Life Sciences Tools and Services |
| P/E Ratio | 32 |
| Return on Equity | 1.56% |
| Beta (1Y) | 0.74 |
| Dividend Yield | 0.00% |
1. Medical Labs & Research-100%
Dishman Carbogen Amcis Ltd is trading at ₹199.10, with a market capitalisation of ₹3,122 Cr.
Dishman Carbogen Amcis Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Life Sciences Tools and Services space (Life Sciences Tools and Services).
Dishman Carbogen Amcis Ltd has a P/E of 32 and a return on equity of 1.56%.